Article

Article detail, metadata, authors, and available full-text links.

Paper reader

Loading paper...

review · 2025

Mavorixafor: a CXCR4 antagonist for WHIM syndrome

Mavorixafor 400mg daily effectively increases WBC count, reduces disease symptoms and infection burden in WHIM syndrome patients ≥12 years. Future clinical p...

1 citationsDOI: https://doi.org/10.1080/08923973.2025.2491551
Mavorixafor: a CXCR4 antagonist for WHIM syndrome